BiotechTube
Home/WinSanTor/Paul Fernyhough
PF

Paul Fernyhough

Co-Founder, Founding KOL

WinSanTor

Therapeutic Areas

Peripheral NeuropathyDiabetic ComplicationsOncology Supportive CareHIV Complications

WinSanTor Pipeline

DrugIndicationPhase
WST-057Peripheral Neuropathy (Diabetic, Chemo-Induced, HIV-Induced)Phase 3

Leadership Team at WinSanTor

SK
Stanley Kim
Chief Executive Officer
NC
Nigel Calcutt
Founding KOL
View full WinSanTor profile